期刊
OPEN FORUM INFECTIOUS DISEASES
卷 9, 期 8, 页码 -出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofac419
关键词
SARS-CoV-2; antigenemia; diagnostics; immunocompromised
资金
- NIH National Cancer Institute [1 U54 CA260563 01]
- NIH [U54 EB027690 03, UL1TR002378]
- Marcus Foundation
Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. Nucleocapsid antigenemia can serve as a marker for persistent infection and therapeutic response in these patients, especially those treated with anti-CD20 immunotherapy.
Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 patients treated with anti-CD20 immunotherapy who acquired severe acute respiratory syndrome coronavirus 2 infection and experienced protracted symptoms. Our results support nucleocapsid antigenemia as a marker of persistent infection and therapeutic response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据